PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩200 per share · Prices as of the 2026-10-02 close
Revenue has expanded for four straight years, but operating margins swing sharply quarter to quarter, keeping the quality of earnings under scrutiny.
2025 consolidated revenue reached KRW 67.97bn, up year on year, but the operating margin fell to 6.6%, below the 2023-2024 levels.
After a net loss attributable to owners in Q2 2025, the company posted four consecutive profitable quarters from Q3 2025 through Q2 2026.
Color cosmetics account for the bulk of revenue, with the product mix diversifying across lip, eye, and base makeup.
Overseas sales, led by Japan, have expanded, and management has referenced plans to enter new regions including the UK, the Middle East, and India.
Operating cash flow turned negative in 2024 amid rising inventory and receivables, before recovering to a surplus in 2025.
Bbia is an indie color cosmetics brand company founded in 2004 that operates multiple brands, Bbia (color), Abouttone (base makeup), Eglips (daily makeup), edit-b (skincare), and Aibb (ultra-low-price color line for teens), focusing on product planning and marketing while outsourcing manufacturing to OEM/ODM partners.
Revenue mix is heavily skewed toward color cosmetics at roughly 78%, with merchandise distribution at about 17% and skincare at about 5%. In 2024, lip makeup accounted for roughly half of color cosmetics revenue, followed by eye and base makeup.
Distribution channels have expanded from the company's own online mall and Zigzag to Olive Young, duty-free stores (Lotte Duty Free Myeongdong and World Tower, Shilla Duty Free), and a flagship store in Seongsu-dong.
Overseas, the company entered Japan through its subsidiary BBIA JAPAN via online platforms such as Qoo10 Japan and Rakuten as well as offline variety stores like Loft and Plaza, with reports citing top rankings for its lip products on local platforms.
CEO Park Gwang-chun took the helm in 2020 when Now IB Capital became the largest shareholder, and the company later listed on KOSDAQ in 2024 through a merger with Shinyoung Happy Tomorrow No. 7 SPAC.
The domestic and global indie beauty space is crowded with rivals such as Tirtir, Chosun Beauty, Anua, and APR, many of which have scaled rapidly through large M&A deals and overseas retail expansion, making competitive intensity high.
Reducing dependence on the color/lip category by broadening the base-makeup and skincare brand lineup has been a core strategic theme in recent years.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩17.4B | ₩200M | 1.1% |
| 2025Q3 | ₩18.7B | ₩1.8B | 9.7% |
| 2025Q4 | ₩16.4B | ₩1.2B | 7.4% |
| 2026Q1 | ₩20.3B | ₩2.9B | 14.5% |
| 2026Q2 | ₩21.8B | ₩1.8B | 8.1% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2023 | ₩38.3B | ₩4.2B | ₩7.7B | 10.9% | 28.4% | 16.0% |
| 2024 | ₩57.6B | ₩5.5B | ₩600M | 9.6% | 1.4% | 20.6% |
| 2025 | ₩68B | ₩4.5B | ₩4.8B | 6.6% | 10.7% | 17.8% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-05
Consolidated revenue rose for three straight years, from KRW 38.27bn in 2023 to KRW 57.64bn in 2024 and KRW 67.97bn in 2025. Yet the operating margin moved in the opposite direction, declining from 10.9% in 2023 to 9.6% in 2024 and 6.6% in 2025 even as sales grew.
Net income attributable to owners swung more sharply, falling from KRW 7.74bn in 2023 to just KRW 0.61bn in 2024 before recovering to KRW 4.76bn in 2025.
Operating cash flow flipped from an inflow of KRW 6.25bn in 2023 to an outflow of KRW 0.98bn in 2024, then recovered to an inflow of KRW 3.15bn in 2025, indicating the disconnect between revenue growth and cash generation was temporary.
On a quarterly basis, Q2 2025 revenue was KRW 17.40bn with operating profit of just KRW 0.19bn and a net loss attributable to owners of KRW 0.18bn.
The company then rebounded in Q3 2025 with revenue of KRW 18.74bn and operating profit of KRW 1.81bn (margin of roughly 9.7%), followed by Q4 2025 revenue of KRW 16.37bn and operating profit of KRW 1.21bn (about 7.4%).
Q1 2026 saw revenue of KRW 20.26bn and operating profit of KRW 2.94bn, lifting the margin to roughly 14.5%, but Q2 2026 revenue hit a quarterly record of KRW 21.80bn while operating profit eased back to KRW 1.77bn (about 8.1%), suggesting revenue scale and margin stabilization have not yet moved fully in tandem.
Summed over the most recent four quarters (Q3 2025 through Q2 2026), revenue totaled roughly KRW 77.16bn, operating profit about KRW 7.74bn, and net income attributable to owners about KRW 7.00bn, an improvement versus the prior full-year figures.
Korean cosmetics exports set another record in the first half of 2026, with small and mid-sized cosmetics exports up 30.7% year on year, ranking as the top export item among SMEs.
The United States has overtaken China as the largest export destination, and much of this growth is attributed to indie brands, marking a structural shift in the industry.
Distribution has moved away from the traditional duty-free and daigou-driven model toward direct online sales via Amazon and TikTok Shop as well as expanded K-beauty curation at offline retailers such as Sephora, Ulta, and Target.
Skincare-focused indie brands such as Chosun Beauty, Anua, Tirtir, and APR have gained particular prominence in this shift, meaning Bbia, which is concentrated in color cosmetics, competes in a comparatively narrower category.
At the same time, large conglomerates such as Amorepacific have also recovered growth momentum in the US, intensifying competition with indie players.
Japan remains a key overseas base amid the broader spread of K-beauty, but exports to China have declined for two consecutive years, highlighting the risk of growth models overly reliant on any single country.
Management has described 2025 as the year the four core brands, Bbia, Abouttone, edit-b, and Eglips, complete their basic lineups, after which the company plans to accelerate entry into new overseas markets including the UK, the Middle East, and India.
Eglips, which had been unable to operate due to a trademark dispute, has since secured the trademark and undergone a full relaunch, making its sales recovery a point to watch for portfolio diversification.
The Japan-based overseas expansion playbook has already shown results and the company appears to be attempting to replicate it in new countries.
With offline retail entry cited industry-wide as a key growth driver for 2026, Bbia and Abouttone's expanded presence in duty-free stores and Olive Young aligns with this trend.
However, no verified quantitative revenue or profit guidance from the company was found, so the contribution of new markets or new products will need confirmation through upcoming quarterly disclosures.
The strategy of broadening beyond the color-cosmetics core into base makeup and skincare appears set to continue, and the level of marketing spend required to sustain this expansion remains a factor to watch for its effect on margins.
Over the past three years, the company's results have shown revenue growth alongside swinging profit margins, and the valuation the market assigns tends to reflect this same volatility.
The stock trades at a level that carries a certain premium to book value, consistent with the valuation pattern typical of growth-stage names.
Because net income fell sharply in 2024 before recovering in 2025, earnings-based valuation metrics can look quite different depending on which period's results are used as the reference point.
The company has a recent history of cash dividends, but as a growth-stage company its policy can be read as prioritizing reinvestment over shareholder distributions. No recent, verifiable target price from a domestic securities firm was found, so none is included in this report.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-05
Net income, which fell sharply in 2024, and operating cash flow, which had turned negative that year, both improved in 2025, confirming a recovery trend. Four consecutive profitable quarters from Q3 2025 through Q2 2026 also support this picture.
However, quarterly operating margins have swung widely between roughly 7% and 15%, so the durability of the improvement will need further quarters to confirm.
Expansion of online and offline channels through its Japan subsidiary has shown results, and the company has cited plans to leverage this experience to enter new markets such as the UK, the Middle East, and India. This can be read as an attempt to reduce dependence on any single country's revenue.
However, the scale of revenue contribution from these new markets has not yet been confirmed through disclosures.
Beyond the color-focused Bbia brand, the company has broadened into base makeup (Abouttone), skincare (edit-b), and an ultra-low-price line (Aibb). Eglips, which had been suspended due to a trademark dispute, has also been relaunched. This can be viewed as reducing the risk of dependence on a single brand or category.
The operating margin declined for three straight years, from 10.9% in 2023 to 9.6% in 2024 and 6.6% in 2025. This appears to reflect rising selling and marketing expenses alongside revenue growth. Even in Q2 2026, when revenue hit a record, the operating margin fell versus the prior quarter.
Net income attributable to owners has swung widely year to year, from KRW 7.74bn in 2023 to just KRW 0.61bn in 2024, before rising again to KRW 4.76bn in 2025. On a quarterly basis, the company posted a net loss in Q2 2025. Judging the quality and sustainability of earnings will require confirmation over several more quarters.
The reliance on OEM/ODM manufacturing lowers barriers to entry for new brands, a factor cited as intensifying competition in the indie beauty market. Rival skincare-focused brands such as Chosun Beauty, Anua, Tirtir, and APR have grown rapidly and scaled up in overseas markets.
As a color-cosmetics-focused player, Bbia must compete with these larger rivals within a relatively narrower category.
Despite revenue growth, the operating margin has declined for three consecutive years, and quarterly margins have ranged widely from roughly 1% to 14%. Expanded marketing and promotional spending could continue to affect margins. Whether margins stabilize will need to be confirmed in coming quarterly results.
During the 2024 revenue surge, growing inventory and receivables pushed operating cash flow into deficit. It recovered to a surplus in 2025, but the business structure, including overseas logistics operations, continues to involve longer inventory turnover. Should growth accelerate again, similar cash flow pressure could recur.
With a high export share, the company is exposed to currency fluctuations and shifts in trade policy across countries. Entering new markets such as the UK, the Middle East, India, and the US carries the risk that tariff, certification, and distribution cost structures could differ from expectations. Should revenue dependence on any single country rise, sensitivity to that country's risks could also increase.
The Q3 2026 quarterly report is due, and it will be important to check whether the operating margin, which eased in Q2, recovers.
This is a point to check for concrete progress, such as retail entry or partnership announcements, on the previously stated plans to enter new overseas markets including the UK, the Middle East, and India.
Year-end promotions at Olive Young and duty-free channels, along with peak-season sales trends on overseas online platforms such as Qoo10 Japan and Rakuten, could affect Q4 results.
The 2026 annual business report (audited financial statements) will confirm full-year results and any dividend policy decisions.
Bbia has extended revenue growth for three consecutive years centered on color cosmetics, but the operating margin has steadily declined over the same period, and net income showed a large swing, dropping sharply in 2024 before recovering in 2025.
The return to four consecutive profitable quarters after a Q2 2025 loss is a positive sign, but the wide range in quarterly operating margins means stabilization still needs further confirmation.
Building on its overseas experience centered on Japan, the company has referenced plans for new markets including the UK, the Middle East, and India, and portfolio diversification is also underway through the Eglips brand relaunch.
However, concrete results from these plans have not yet been confirmed through disclosures. Competitive intensity remains elevated as skincare-focused indie rivals grow rapidly within an OEM/ODM-based industry structure with low entry barriers.
Inventory and receivables management, along with the level of marketing spend, appear to be the key variables that will determine the direction of margins going forward, and upcoming quarterly results and news on new market entry should be monitored to see whether these trends continue.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.